| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |